We write about change — about impact and consequences, about discoveries and the people behind them. This time, we introduce you to Roosmarijn Vandenbroucke, a discovery scientist at IRC-VIB and a professor at Ghent University. She gives us an eagle’s-eye view of her group’s latest research, which has the potential to impact the management of patients with neurodegenerative and neuroinflammatory diseases.
Pierre Collet, professor in Computer Science at Strasbourg University, is one of the key opinion speakers at the BioWin Day 2016. He works on artificial evolution, the human physiome and complex system sciences. He is multitalented and has a clear vision of how science can be accelerated on a global scale. BioVox had the honor to interview him in advance of his speech at BioWin Day.
In 2013, a new BioWin project, NeuroAtt, was launched to arrive at a reliable diagnosis for ADHD (Attention Deficit Hyperactivity Disorder) and to find the least [...]
Mutations in mitochondrial DNA can cause severe diseases and fertility problems. Since mitochondria are only inherited from the mother, a mother with faulty mitochondrial DNA will pass this on to her children without exception. Techniques involving the use of a donor egg with healthy mitochondria were developed to avoid this. However, the fact that the resulting embryo contains genetic material from three different individuals raised many ethical questions. Also, the science behind mitochondrial transfer hasn’t been fully elucidated. Nonetheless, a scientific group from New York went ahead and applied the techniques, and last April, a three-parent baby was born.